» Articles » PMID: 25236394

Exosomes As Divine Messengers: Are They the Hermes of Modern Molecular Oncology?

Overview
Specialty Cell Biology
Date 2014 Sep 20
PMID 25236394
Citations 148
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are cell-derived vesicles that convey key elements with the potential to modulate intercellular communication. They are known to be secreted from all types of cells, and are crucial messengers that can regulate cellular processes by 'trafficking' molecules from cells of one tissue to another. The exosomal content has been shown to be broad, composed of different types of cytokines, growth factors, proteins, or nucleic acids. Besides messenger RNA (mRNA) they can also contain noncoding transcripts such as microRNAs (miRNAs), which are small endogenous cellular regulators of protein expression. In diseases such as cancer, exosomes can facilitate tumor progression by altering their vesicular content and supplying the tumor niche with molecules that favor the progression of oncogenic processes such as proliferation, invasion and metastasis, or even drug resistance. The packaging of their molecular content is known to be tissue specific, a fact that makes them interesting tools in clinical diagnostics and ideal candidates for biomarkers. In the current report, we describe the main properties of exosomes and explain their involvement in processes such as cell differentiation and cell death. Furthermore, we emphasize the need of developing patient-targeted treatments by applying the conceptualization of exosomal-derived miRNA-based therapeutics.

Citing Articles

Prominosomes - a particular class of extracellular vesicles containing prominin-1/CD133?.

Karbanova J, Thamm K, Fargeas C, Deniz I, Lorico A, Corbeil D J Nanobiotechnology. 2025; 23(1):61.

PMID: 39881297 PMC: 11776279. DOI: 10.1186/s12951-025-03102-w.


Exosome Mediated Cell-Cell Crosstalk in Tissue Injury and Repair.

Yadav A, Nandy A, Sharma A, Ghatak S Results Probl Cell Differ. 2024; 73:249-297.

PMID: 39242383 DOI: 10.1007/978-3-031-62036-2_12.


MicroRNAs: Potential prognostic and theranostic biomarkers in chronic lymphocytic leukemia.

Ali A, Mahla S, Reza V, Hossein A, Bahareh K, Mohammad H EJHaem. 2024; 5(1):191-205.

PMID: 38406506 PMC: 10887358. DOI: 10.1002/jha2.849.


Multifunctional Exosomes Derived from M2 Macrophages with Enhanced Odontogenesis, Neurogenesis and Angiogenesis for Regenerative Endodontic Therapy: An In Vitro and In Vivo Investigation.

Wang Y, Mao J, Wang Y, Jiang N, Shi X Biomedicines. 2024; 12(2).

PMID: 38398043 PMC: 10886856. DOI: 10.3390/biomedicines12020441.


Exosomes-mediated drug delivery for the treatment of myocardial injury.

Li J, Lin A, Jiang R, Chen P, Xu C, Hou Y Ann Med Surg (Lond). 2024; 86(1):292-299.

PMID: 38222684 PMC: 10783224. DOI: 10.1097/MS9.0000000000001473.


References
1.
Clayton A, COURT J, Navabi H, Adams M, Mason M, Hobot J . Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods. 2001; 247(1-2):163-74. DOI: 10.1016/s0022-1759(00)00321-5. View

2.
El-Andaloussi S, Lee Y, Lakhal-Littleton S, Li J, Seow Y, Gardiner C . Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc. 2012; 7(12):2112-26. DOI: 10.1038/nprot.2012.131. View

3.
Stahl H, Fauti T, Ullrich N, Bopp T, Kubach J, Rust W . miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression. PLoS One. 2009; 4(9):e7158. PMC: 2743997. DOI: 10.1371/journal.pone.0007158. View

4.
El Andaloussi S, Mager I, Breakefield X, Wood M . Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013; 12(5):347-57. DOI: 10.1038/nrd3978. View

5.
Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View